Tuesday, 02 January 2024 12:17 GMT

Systemic Challenges In US Health Care Push Cancer Patients To Fly To China


(MENAFN- Investor Brand Network) For decades, lots of American patients have been traveling to“fringe” countries like Turkey, Cuba and Thailand in search of affordable, quality healthcare due to the persistent challenges plaguing the American health care system. Now the latest destination of choice for cancer treatment is China, according to a report by the WSJ (Wall Street Journal).

For firms like Calidi Biotherapeutics Inc. (NYSE American: CLDI) that are also conducting R&D programs aimed at commercializing the next wave of immunotherapies, affordability is a major concern because it may not be helpful to...

Read More>>

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

MENAFN15092026000224011066ID1111670878



Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story